CLEC2D expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.171400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.030600E-01
Normal-vs-Stage2
4.239000E-01
Normal-vs-Stage3
3.826000E-01
Normal-vs-Stage4
3.936000E-01
Stage1-vs-Stage2
3.960400E-01
Stage1-vs-Stage3
4.633400E-01
Stage1-vs-Stage4
7.576600E-01
Stage2-vs-Stage3
3.895900E-02
Stage2-vs-Stage4
6.632200E-01
Stage3-vs-Stage4
6.797600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.228000E-01
Normal-vs-AfricanAmerican
3.878400E-01
Normal-vs-Asian
3.687000E-01
Caucasian-vs-AfricanAmerican
1.969250E-01
Caucasian-vs-Asian
9.362400E-03
AfricanAmerican-vs-Asian
4.690200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.111200E-01
Normal-vs-Female
4.253400E-01
Male-vs-Female
5.026200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.082200E-01
Normal-vs-Age(41-60Yrs)
4.481600E-01
Normal-vs-Age(61-80Yrs)
4.017600E-01
Normal-vs-Age(81-100Yrs)
4.257000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.573600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.504600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.356400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.660300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.142200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.271800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.243200E-01
Normal-vs-Daily Drinker
3.980200E-01
Normal-vs-Weekly Drinker
3.733000E-01
Normal-vs-Occasional Drinker
4.163200E-01
Normal-vs-Social Drinker
4.664200E-01
Non Drinker-vs-Daily Drinker
3.909600E-01
Non Drinker-vs-Weekly Drinker
6.272400E-02
Non Drinker-vs-Occasional Drinker
8.327600E-01
Non Drinker-vs-Social Drinker
5.923400E-01
Daily Drinker-vs-Weekly Drinker
2.289200E-01
Daily Drinker-vs-Occasional Drinker
5.980400E-01
Daily Drinker-vs-Social Drinker
3.408200E-01
Weekly Drinker-vs-Occasional Drinker
1.880610E-01
Weekly Drinker-vs-Social Drinker
1.720380E-01
Occasional Drinker-vs-Social Drinker
5.233800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.117400E-01
Normal-vs-Grade 2
1.464780E-01
Normal-vs-Grade 3
2.698600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.788200E-01
Grade 1-vs-Grade 3
7.506200E-01
Grade 1-vs-Grade 4
5.117400E-01
Grade 2-vs-Grade 3
9.081800E-01
Grade 2-vs-Grade 4
1.464780E-01
Grade 3-vs-Grade 4
2.698600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.356400E-01
Normal-vs-NonDiabetic
4.054600E-01
Diabetic-vs-NonDiabetic
2.073000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.790400E-01
Normal-vs-NoPancreatitis
4.095000E-01
Pancreatitis-vs-NoPancreatitis
4.450800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.239600E-01
Normal-vs-N1
4.167600E-01
N0-vs-N1
8.239000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.967600E-01
Normal-vs-TP53-NonMutant
4.319600E-01
TP53-Mutant-vs-TP53-NonMutant
2.409400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
